CANY
IPHS

Caxton Associates (New York)’s Innophos Holdings, Inc. IPHS Stock Holding History

Caxton Associates (New York)’s Portfolio IPHS Stock Details IPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,418
Closed -$400K – 602
2017
Q1 		$400K Buy
+7,418
New +$383K ﹤0.01% 309

Other funds holding IPHS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Caxton Associates (New York)'s IPHS Position: Q2 2017 in Review

Caxton Associates (New York) sold out of Innophos Holdings, Inc. (IPHS) in Q2 2017, closing a stake of 7,418 shares — an estimated $400K sold.

Caxton Associates (New York) first reported a position in IPHS in Q1 2017 and held it in 1 quarter. The position peaked at $400K in Q1 2017. 177 funds tracked by Wall St. Rank hold IPHS as of Q2 2017.

  • Caxton Associates (New York) reported no remaining Innophos Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
  • Caxton Associates (New York) sold 7,418 Innophos Holdings, Inc. shares in Q2 2017, an estimated $400K.
  • Caxton Associates (New York) first reported a position in Innophos Holdings, Inc. in Q1 2017 and held it in 1 quarter.
  • Caxton Associates (New York)'s Innophos Holdings, Inc. position peaked at $400K in Q1 2017.
  • 177 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q2 2017.

Based on Caxton Associates (New York)'s 13F filing for Q2 2017, filed 14 Aug 2017.